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The process of blood formation is sustained throughout an individual's life by a small 
population of haemopoietic stem cells (HSCs). The HSC compartment represents a
hierarchy of HSC subsets with decreasing proliferative ability. This heterogeneity is 
reflected in the varying time periods that HSCs may contribute to the initiation and 
maintenance of donor-type haemopoietic multilineage chimerism in vivo. The phenotype 
of HSC is incompletely defined rendering morphological or flow cytometric quantitation 
unreliable. Functional HSC assays, both in vitro (CAFC, LTC-IC) and in vivo (re- 
population of NOD/SCID mice) may be superior to phenotypic analysis; however, such 
assays have not been truly validated in a human transplant setting. 
The quiescence and proliferation of HSCs is highly regulated by the stroma in 
haemopoietic organs. Many of the cytokines that have been cloned in recent years are 
actually elaborated and presented by the haemopoietic organ stroma nd are supposed to 
serve as local regulators inorder to gain specificity and avoid pleitropic and thus undesired 
side effects. Most probably, additional stroma-derived factors will be characterized as
suggested by the observation that HSCs produce more progeny in stroma-contact than in 
its absence or in stroma-conditioned medium, irrespectively of the exogenous cytokines 
included, 
Stem cells are considered topossess the ability to self-renew and are therefore attractive 
vehicles for gene therapy. The same assumed characteristic fuels attempts o amplify their 
numbers ex vivo, and is expected to enable more rapid haemopoietic recovery of 
conditioned recipients as well as enlarge HSC grafts of insufficient size before actual 
transplantation. 
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Haemopoiet ic  stem cells (HSCs)  are pr imit ive cel ls that maintain b lood cell  
product ion throughout an indiv idual 's  l i fet ime. In the adult, most are 
located in the bone marrow and can migrate in a highly regulated fashion 
via the b lood stream between the widely d ispersed areas of  haemopoiet ic  
activity. 
The HSC compartment  is heterogeneous in various aspects, poss ib ly  as 
a result of  the different mitot ic  histories of  each stem cell,  caused by 
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stochastic mechanisms that regulate cycling activity in a predominantly 
resting stem cell population (Korn et al, 1973; Nakahata et al, 1982). 
Analogous to the mouse, the human HSC compartment is likely to 
represent a hierarchy of primitive cells based on decreasing ability to 
generate new HSCs, decreasing pluripotentiality and proliferative potential, 
and increasing turnover ate (Rosendaal et al, 1979; Mauch et al, 1980; 
Hodgson and Bradley, 1984; Ploemacher and Brons, 1989; Ploemacher et 
al, 1991, 1993b; Ploemacher, 1994). For transplants, this heterogeneity 
may be reflected in the different ime periods which individual stem cell 
clones contribute to long-term reconstitution of a conditioned host, 
irrespective of whether this includes all haemopoietic lineages (Lemischka 
et al, 1986; Capel et al, 1990; Harrison, 1992; Lemischka, 1992; Van der 
Loo et al, 1994; Ploemacher, 1994). The question then arises as to what 
should be denoted as a 'stem cell'. It is generally accepted hat HSCs have 
a very low turnover ate, but considerable capability of both self-renewal 
and differentiation i to at least eight haematolymphoid lineages. 
HOW DO STEM CELLS MAINTAIN THEMSELVES 
THROUGHOUT AN INDIVIDUAL'S LIFE? 
Many papers have been devoted to HSC 'self-maintenance' and the high 
expectations of 'ex vivo expansion of HSCs' and gene therapy comes from 
the acceptance of HSC immortality. However, there is no extensive 
evidence for HSC immortality and it should be questioned whether such a 
cell population would not endanger the integrity of life because it has 
qualities reminiscent of a neoplasia. Second, immortality could be inter- 
preted in a semantic manner, so that a future potential of 50 cell divisions 
meets conditions of virtual self-maintenance. For example, the recent 
demonstration that lymphomyeloid-repopulating HSCs can expand their 
numbers greater than 300-fold following their transplantation i a 
conditioned recipient is impressive indeed, but takes a mere eight cell 
divisions with full self-renewal (Pawliuk et al, 1996). 
Third, a clear distinction should be made between maintenance of an 
individual stem cell and that of an HSC population as a whole. The well- 
known cartoon of an individual stem cell that divides and produces two 
distinct daughter cells, one remaining 'stem cell' and the other committing 
itself to differentiation, may not be commonplace. Instead, operational 
terms should be used which apply to the whole population and characterize 
the HSC compartment as a cell population with a probability of self- 
renewal approaching 0.5. Alternatively, a population could be structured 
such that i uses a (small) number of cells as a reserve compartment, while 
the largest part is responsible for the daily supply of differentiated progeny. 
This structure can be recognized in many tissues. There is ample evidence 
for a metabolically quiescent HSC population with relatively low turnover 
that harbours a high proliferative potential and probability to give multi- 
lineage offspring. Many observations suggest that in the steady state only a 
few stem cell clones display clonogenic expansion at the same time and 
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contribute to daily blood cell production (Lemischka et al, 1986; Snodgrass 
and Keller, 1987; Capel et al, 1989; Abkovitz et al, 1990; Jordan and 
Lemischka, 1990; Lemischka, 1992). In transplants many different clones 
contribute to the initial phase of haemopoietic reconstitution, but within 
weeks only a few remain to provide for the demand of the body for blood 
cells. In contrast, the work of Harrison and colleagues upports a model 
where HSCs function continuously (Harrison et al, 1988; Harrison, 1992). 
The ultimate self-renewal capacity of HSCs is unknown, but serial trans- 
plantation studies in mice and reports on chromosome t lomere shortening 
in humans uggest that human HSC self-replication is limited to around 50 
cell divisions (Vaziri et al, 1994). Extinction of individual clones feeds back 
into the quiescent HSC compartment and triggers proliferation of other 
HSCs. 
REGULATION OF HSC QUIESCENCE AND PROLIFERATION 
The mechanisms regulating cycle activity and facilitating undifferentiated 
proliferation of HSCs are not completely understood and many cytokines 
have recently been shown to act synergetically in inducing proliferation of 
candidate HSCs. These factors may have growth factor activity when used 
as a single factor. Their action may therefore be explained by a series of 
assumptions, including (a) competence acquisition, i.e. they induce Go> GI 
transition in an HSC without being able to drive cells through S-phase and 
G2 to mitosis (Suda et al, 1983), (b) they induce or upregulate receptor 
expression for other cytokines that can activate HSCs, (c) they down- 
regulate receptors for negative regulators of HSCs or (d) the downstream 
targets of receptor-ligand complexes, the transcription molecules, act in 
concert o affect molecular processes essential for regulation. Many small 
molecules have been proposed as HSC-specific; however, none has been 
confirmed. The most important inhibitors are transforming growth factor- 
]31 (TGF-[51), tumour necrosis factor-o~ (TNF-~I), interferon-y (IFN-7) and 
macrophage inflammatory protein-1 o~ (MIP-1 o~). They are often pleiotropic 
factors that may have both stimulatory and inhibitory properties on differ- 
ent cell populations. For example, TGF-[51 stimulates monocyte cluster 
formation and at the same time is the most active inhibitor at the stem cell 
level (Ottmann and Pelus, 1988; Hampson et al, 1989; Hatzfeld et al, 1991; 
Ruscetti et al, 1991; Ploemacher t al, 1993a). 
Cytokines that are effective in regulation of HSC proliferation, most 
likely in a redundant or overlapping fashion and often in synergy, are stem 
cell factor (SF; a ligand for the c-kit receptor), tyrosine kinase receptor 3
ligand (Flt3-L), thrombopoietin (Tpo, a ligand for c-mpl), interleukin-6 
(IL-6), IL-11, IL-3, leukaemia inhibitory factor (LIF) and granulocyte 
colony-stimulating factor (G-CSF). The sources of these factors vary and 
can be autocrine, paracrine (e.g. elaborated by stromal cells in the bone 
marrow environment; T-cells or monocytes) or endocrine. The above 
molecules certainly do not act exclusively on HSCs proper and therefore 
specificity requires local presentation in context with other signals, possibly 
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cell-cell and cell-extracellular matrix contact mediated by cell adhesion 
molecules (CAM) (see Chapter 4). 
In addition to soluble factors elaborated by stromal cells and HSC, there 
could exist other more intimate levels of regulation of HSCs. Rather than 
exclusively determining HSC sub-localization i  the haemopoietic organs, 
CAM could have direct regulatory effects on HSCs. For example, an 
antibody against LFA-1 inhibits the generation of progenitor cells by a 
fraction of human HSCs in stroma-supported cultures (Gunji et al, 1992). 
Perhaps the best studied CAM interaction is that of c-kit and its ligand, 
SF (Kodama et al, 1994). SF is a receptor on stromal cells in, for example, 
bone marrow, reproductive organs (Sertoli cells in testes and follicular cells 
in ova), skin and cerebellum, whereas c-kit is the SF receptor expressed on 
immature cells including HSC, spermatides, oogonia and melanocytes 
(Yoshinaga et al, 1991; Nishikawa et al, 1991; Hirata et al, 1993; Ogawa et 
al, 1993; Packer et al, 1994). Loss of SF from the stromal cell membrane 
leads to a pleiotropic phenotype in mice (the Steel phenotype), that includes 
macrocytic anaemia, decreased fertility and coat colour defects. This 
condition largely develops as a result of a defective stem cell migration 
during embryogenesis and the anaemia in adult mice cannot be normalized 
by infusion of the soluble receptor SF, although the soluble receptor SF 
acts as survival factor, growth factor and a potent synergistic activity in 
vitro. 
From embryogenesis it has become evident that genuine cell--cell 
communication may be even more intimate and involve coupling of intra- 
cellular compartments of adjacent cells via gap junctions (G J). The 
Connexin-43 (Cx43) type GJ can be detected immunohistologically in bone 
marrow and its expression i creases 80 to 100-fold in murine bone marrow 
during the neonatal period and shortly after cytoreductive treatment of 
adult mice during the period when active regeneration is beginning 
(Rosendaal et al, 1994). We recently reported that functional blocking of all 
GJ intercellular communication (GJIC) between mutual stromal cells and 
stromal and haemopoietic cells in long-term culture (LTC) and cobblestone 
area forming cell (CAFC) cultures (see later) substantially inhibited 
haemopoietic a tivity. This inhibition could be fully abrogated by restoring 
GJIC within the first 2 weeks of culture (Ploemacher et al, in press; 
Rosendaal et al, in press). 
It can not be excluded that there exist ystemic or endocrine signals that 
regulate or verrule this complex local signalling network if decisive action 
is required following, for example, blood loss, infection or cytoreductive 
therapy. 
MEASUREMENT OF STEM CELL ACTIVITY 
Because of their low frequencies and lack of physical characteristics HSC 
measurements rely on functional assays. HSCs have been defined ascells 
that have high proliferation potential, can self-renew and give rise to multi- 
potential lineage development. Therefore, HSC assays commonly use these 
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characteristics a an endpoint. In vivo, spleen colony formation (Till and 
McCulloch, 1961), animal survival, competitive repopulation (Harrison et 
al, 1988; Harrison 1992), retransplantation (Lemischka et al, 1986; 
Spangrude t al, 1995) and engraftment of mice having a congenital 
immune-suppression (Lapidot et al, 1992), anaemia (Boggs et al, 1982; Van 
der Loo et al, 1994; Ploemacher, 1994) or polymorphism in an enzyme 
(Down and Ploemacher, 1993) or cell surface epitope (Szilvassy et al, 
1989; Pawliuk et al, 1996) have been used to detect HSCs and their 
descendants. In vitro, clonogenic potential (Pluznik and Sachs, 1965; 
Bradley and Metcalf, 1966) with particular ttention for multipotential or
blast-colony formation (Tsuji et al, 1991) and replating efficiency, short- 
term liquid (delta) cultures (Muench and Moore, 1992; Moore and Hoskins, 
1994; Petzer et al, 1996; Srour et al, 1996) and long-term progenitor cell 
production on stromal cells (Dexter et al, 1977; Gartner and Kaplan, 1980; 
Sutherland et al, 1990, 1991; Breems et al, 1994) have been employed. 
The effectiveness and reliability of such assays depends on many 
parameters, including 
• HSC seeding efficiency to a specific haemopoietic organ in vivo, 
• knowledge about, and availability of, growth factor combinations 
required to activate the most quiescent HSCs tocycle in vitro, 
• insight in what context cytokines hould be presented to HSCs (e.g. 
bound to stromal cell surfaces or extracellular matrix molecules), 
• knowledge of inhibitors that maintain quiescence of HSCs, and 
methods to neutralize or counteract their activities, 
• the time required to activate the most quiescent HSCs and 
• stochastic mechanisms operating at the HSC level that determine 
quiescence/cycling ratio and commitment into specific differentiation 
lineages. 
The latter issue clearly demonstrates the limitation of HSC techniques in 
that HSCs may not behave according to their ascribed ability for multi- 
potential differentiation and self-renewal capacity. As discussed by 
Lemischka (1992) on the basis of extensive transplantation experiments 
with provirus-marked HSC, analysis of a reconstituted haemopoietic 
system at a single point in time merely defines a grafted HSC in terms of 
its minimal differentiation a d proliferation potential. Therefore, estimation 
of HSC self-renewal should be preferentially done by analysis at multiple 
points in time and transplantation into secondary hosts. 
Finally, of concern is that human in vitro assays are difficult to validate, 
so assumptions have to be made on the basis of single case histories and 
through extrapolation of the better characterized murine and large animal 
models. 
Stem cell assays 
Various assays have been claimed to exclusively detect HSCs and even 
allow their enumeration. It should be realized that a genuine assay should 
(a) allow frequency assessment independent of the accompanying cells in 
434 g.E. PLOEMACHER 
the sample or the HSC purity, (b) be validated using in vivo endpoints and 
(c) permit indisputable identification of the endpoint. There is perhaps no 
assay that meets these requirements. 
The first issue deals with the presence or absence of progenitor cells and 
bystander cells. For example, though properly stimulated HSCs from 
various sources may form colonies in semi-solid medium, such colonies 
would be outnumbered by progenitor-derived colonies by a factor of 
5 x t0~-5 x 105. These figures are based on the observation of 300-500 
colony-forming units in culture (CFU-C)/105 bone marrow cells (BMCs), 
while primitive HSCs have been reported to have a frequency of 10-20/10 s 
BMCs as estimated using LTC-IC week-5 (long term culture initiating cell) 
and CAFC week-6 in stroma-supported LTCs (Sutherland et al, 1990; 
Breems et al, 1994) or even 1/1-6 x 106 using repopulation of cytokine- 
treated NOD/SCID (non-obese diabetes/severe combined immuno- 
deficiency disease) mice as an endpoint (Larochelle t al, 1996; Dick, 
1996). In addition, both progenitor and assessory cells elaborate cytokines 
and inhibitors, and consequently affect he outcome of the HSC assay. 
The second requirement, one that is underrated and frankly unpopular, is
that of proper assay validation. In the past 50 years it has been proposed 
that haemopoietic rescue from radiation-inflicted death could be induced by 
transfusion of body fluids, spleen homogenates, spleen or bone marrow cell 
suspensions, spleen colony-forming cells (CFU-S; cells that can form 
haemopoietic nodules in the spleen of an irradiated mouse) or long-term 
repopulating HSCs that have extremely low CFU-S quality. As mentioned, 
many types of in vitro assay methods claim to score 'stem cell quality'. 
Proof depends on the acceptance of a stem cell definition, and the ability to 
sort the target ceils to high purity and show that the cells comply with the 
spirit of such a definition. 
Third, the most relevant assays for HSC enumeration are those that have 
a unique endpoint, which is characteristic for HSCs, and thus discriminates 
HSCs from accompanying progenitors in the sample. In practice this 
includes all assays that detect long-term (multilineage) activity of HSCs in 
vivo or in vitro. 
Long-term cultures 
One such method is the stroma-dependent LTC of haemopoietic cells, 
which is routinely performed in 25 cm 2 flasks (Dexter et al, 1977). LTC 
measures the capacity of a complement of inoculated cells to generate 
haemopoietic progenitor cells over a number of weeks, typically 5-8 
weeks. Progenitor cells can be detected in the non-adherent cell fraction 
that is harvested weekly during medium changes, and in the adherent layer 
that can be harvested by trypsinization. The LTC thus gives an insight in the 
capacity of a graft to produce progenitor cells, while it remains unknown 
how many HSCs and progenitors contribute to it. The latter is highly 
relevant when differences are anticipated in the progenitor cell generating 
capacity of HSCs, for example, on the basis of disease, chemotherapy or 
following ex vivo strategies for physical or chemical purging or selection. 
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In order to allow such HSC enumeration, limiting dilution type 
miniaturized LTC have been reported that either use CFU-C production 
(LTC-IC; Sutherland et al, 1990) or stroma-associated clone formation 
(CAFC; Ploemacher t al, 1989, 1991; Breems et al, 1994; Pettengell et al, 
1994) as an endpoint for frequency calculation. 
The CAFC assay is assumed to detect frequencies of the various HSC 
subsets with 'transient repopulating' and/or 'long-term repopulating' 
properties, and has been developed as an extrapolation from the murine 
CAFC assay (Ploemacher et al, 1989, 1991, 1993b; Ploemacher, 1994). 
Extensive studies using physically sorted BMC have allowed regression 
analysis on the applicability of the murine CAFC assay as an in vitro 
equivalent for a series of HSC subsets in vivo. These studies have indicated 
that both in vivo and in vitro early developing, short-lived clones are 
initiated by the transient repopulating CFU-S cells (day-12), whereas later 
developing and more permanent clones are descendants of more primitive 
long-term repopulating HSCs, that induce stable chimerism for more than 
a year (Ploemacher tal, 1991, 1993b; Ploemacher, 1994; Van der Loo et 
al, 1994). There is increasing evidence that the human CAFC assay may 
also detect ransiently and long-term repopulating normal and leukaemic 
stem cell subsets (Winton and Colenda, 1987; Terpstra et al, 1996a,b; 
Cornelissen et al, 1997; Breems et al, 1996, 1997). Recently a good 
correlation was found between CAFC week-7 and cells that repopulate 
SCID-hu mouse bone implants 8 weeks post-engraftment, using human 
mobilized peripheral blood cells that were sorted on the basis of Thy-1 
expression within a CD34 + (cells expressing CD34 surface marker), Lin- 
(cells not expressing lineage-specific cell surface markers) population 
(Murray et al, 1995). In addition, early detectable CAFCs have the 
characteristics of the more differentiated and transiently repopulating HSCs 
(5-fluorouracil (5-FU)-sensitive, CD34 me°iunup°siti'c, CD38 m~diun~igh, HLA- 
DRhi~), whereas late CAFCs meet the phenotype routinely employed for 
primitive HSCs, i.e. 5-FU-resistant, CD34 high, CD38 °°g~'~'°j"~d~"" andHLA- 
DR m°W/a~" (Breems et al, 1994; R. E. Ploemacher, unpublished observations). 
Both the flask LTC and CAFC assays propagate successive clonal 
amplification of HSC subsets at their own expense (Fraser et al, 1990; Van 
der Sluijs et al, 1993). This property renders the CAFC assay useful in 
assessing the full haemopoietic potential of a marrow specimen in a 
relatively short period and in presenting a quantitative cross-section of the 
heterogeneous stem cell compartment. 
Extended long-term cultures 
Extended stroma-dependent LTC (ELTC; 8-14 weeks) have recently been 
described (Hao et al, 1996) which may reveal an even more primitive human 
HSC population than that detected in regular LTC (5 weeks) and CAFC (6-8 
weeks) assays. ELTC-initiating cells (ELTC-IC) differ from LTC-IC in 
various respects. First, ELTC-ICs produce most CFU-C after 60 days, 
whereas LTC-IC do so earlier. It is not currently clear whether these differ- 
ences are realistic or merely result from the use of different stromal support 
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layers, cytokine combinations, era and the monthly total replate to other 
stromal layers that is reported for the ELTCs. Second, in contrast to LTC-IC, 
which show a high level of gene marking (Larochelle et al, 1996; Hao et al, 
1996), only about 1% of ELTC-ICs can be transduced. The latter character- 
istic is reminiscent of the low transduction efficiency of long-term repopulat- 
ing cells in human clinical gene therapy trials and most large animal models 
(Bordignon et at, 1995; Dunbar et al, 1995; Kohn et al, 1995; Fruehauf et al, 
1996; Hoogerbmgge etal, 1996). Finally, ELTC-ICs are exclusively found 
in the CD38 fraction of CD34 ÷ cells, as a human SCID-repopulating cells 
(SRCs; Larochelle et al, 1996). In contrast, part of LTC-ICs and CAFC week 
6 are CD38 "~ (R.E. Ploemacher, unpublished observations). 
SCID mouse assay 
The propagation of human haemopoietic progenitors in mice with a severe 
combined immuno-deficiency s ndrome has dramatically extended our 
insight into the repopulating abilities and frequencies of primitive human 
HSCs (Baum et al, 1992; Lapidot et al, 1992; Nolta et al, 1994; Vormoor et 
al, 1994; Larochelle t al, 1996). Grafted human HSCs proliferate in SCID 
mice and differentiate in the murine bone marrow to produce large numbers 
of LTC-ICs, CFU-Cs, immature CD34p°~Thyl p°S and CD34p°sCD38 n°g cells, 
as well as mature myeloid and erythroid cells. Relatively large numbers of 
lymphoid cells are produced in the bone marrow, and the human engraft- 
ment of the murine thymus and spleen is almost exclusively lymphoid. 
Frequencies of the primitive cells that initiate the graft in sub-lethally 
irradiated NOD/SCID mice, the SCID-repopulating cells, are extremely 
low: there is about one human SRC in every 10 ~ umbilical cord blood 
(UCB) cells, one in 3 x 10 ~ adult BMC and only one in 6 x 106 mobilized 
peripheral blood (PB) cells (Dick, 1996; Larochelle et al, 1996). These 
frequencies are far lower than estimated by the LTC-IC and CAFC assays: 
average CAFC week 8 numbers in all of these specimens are between 1-10 
per 105 cells. It is likely that these differences are partly due to a low 
seeding efficiency of the human HSC in these mice (van Henrick, un- 
published ata). For example, in SCID mice a 5-10-fold higher engraft- 
ment with human AML cells has been reported following pre-treatment of
the recipients with macrophage-depleting C12MDP liposomes (Terpstra et 
al, 1996a). Also, the different growth requirements of these cells may affect 
the apparent frequencies in NOD/SCID mice. UCB cells grow spon- 
taneously in SCID mice, but PB and BM stem cells need continuous 
cytokine support following their transplantation. 
Characterization of HSCs 
In the last four decades the description of HSC characteristics has been a 
reflection of methods, techniques and hardware available to investigators. 
HSCs emerged as typically small 'blast' cells with a relatively low buoyant 
density and sedimentation velocity, few and small mitochondria,  nucleus 
with several nucleoli and little condensed chromatin. Agreeing with these, 
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they concentrate in a region of relatively low side and forward light scatter 
in a flow cytometer. Physical isolation studies using fluorescence-activated 
cell sorter (FACS) have shown that human HSCs express on their cell 
surface: CD34, c-kit-R, IL-6R brightly; Thy-1, CD45RA and Flt3, weakly; 
but not lineage-specific markers, HLA-DR, CD71, CD38 or CD33. HSCs 
share some of these characteristics with other cells, and therefore pheno- 
typical identification and enumeration of HSC is still not truly feasible. 
The nucleic acid dye Hoechst 33342, which hardly stains the most 
quiescent HSCs, has been extremely helpful in HSC isolation, as has the 
vital fluorochrome Rhodamine-123 (Rh123). Rh123 accumulates in 
mitochondria and is a substrate of the mdr-1 gene product, the membrane 
pump P-glycoprotein (Chaudhari and Roninson, 1991; Fruehauf et al, 
t996), that is highly expressed in quiescent HSC. For these reasons 
primitive HSCs hardly stain with Rh123 (Ploemacher and Brons, 1988a,b; 
Craig et al, 1993; Breems et al, 1994; Leemhuis et al, 1996), but within the 
HSC compartment Rh123 retention increases dramatically so that the 
murine day-12 spleen colony forming cells are among the brightest Rh123- 
stained cells in the bone marrow (Ploemacher and Brons, 1988a,b). 
Because of their relative quiescence, primitive HSCs have been shown to 
be especially resistant to anti-mitotic agents (e.g. hydroxyurea, vincristine) 
and 5-FU (Hodgson and Bradley, 1984; Ploemacher tal, 1991; Breems et al, 
1994). This property has been exploited to enrich HSCs by exclusion of all 
other cells (Berardi et al, 1995). In contrast, the most primitive and in vivo 
long-term repopulating HSCs, as well as CAFC week 5, are extremely 
sensitive to the alkylating agent busulphan and a number of its derivatives 
(Down and Ploemacher, 1993; Down et al, 1994). A long held view is that 
HSCs in general represent one of the most radiosensitive c ll types in the 
body, with aD o of about 0.75 Gy and no sub-lethal damage (SLD) repair. This 
results from radiation studies carried out using the CFU-S day-7-9 assay and 
animal survival as endpoints. However, current views are more in line with 
the realization that both these methods are a measure of transient repopulat- 
ing HSCs (Ploemacher and Brons, 1988a,b, Ploemacher and Brons, 1989). 
The recognition of heterogeneity n the HSC compartment and the develop- 
ment of the CAFC assay allowing the estimation of HSC subset frequencies, 
and thus radiation survival, has led to a more balanced appraisal of the HSC 
compartment radiosensitivity. It is the CFU-S day-7/CAFC day-7-10 
population that shows high radiation sensitivity and lack of SLD repair 
(Meijne et al, 1991, 1992; Ploemacher et al, 1992), but with increasing 
primitivity CAFC subsets are far more radio-resistant and display high levels 
of SLD repair, matching or surpassing that of lung tissue (Down et al, 1995). 
All of these characteristics have emerged from studies on HSC from adult 
donors and may, or may not, apply to HSC from other developmental stages. 
AREAS OF FURTHER RESEARCH 
The enrichment and in vivo expansion of HSCs using a variety of 
techniques and cytokine cocktails have created novel areas of applied 
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research. The possible therapeutic applications for primitive HSCs are 
many and varied. HSCs and progenitor cells have become the vehicle of 
choice for administering certain genes therapeutically, including genes to 
treat metabolic disorders, inherited immune and haematological diseases, 
and acquired immune deficiency syndromes. However, although experi- 
mental data on efficient gene transfer and long-term gene expression in 
mice have boosted expectations for clinical application of gene therapy, the 
human data have been extremely disappointing. Low transduction rates of 
haemopoietic cells, limited lineage expression and diminishing numbers of 
transduced cells observed after transplantation have necessitated a ditional 
basic research (see Chapter 2). 
With increasing information on the number, quality and characteristics of 
HSCS in UCB, this material has been efficacious as an alternative source of 
HSCs for transplantation in children (Broxmeyer et al, 1995). Transplants 
with UCB have utilized about 10-fold smaller numbers of nucleated cells 
than comparable transplants with BMC. However, it is believed that UCB 
contains a greater proportion of progenitors than BM and that their 
proliferative capacity as determined by colony replating, stroma-supported 
growth in LTC, and SCID mouse engraftment is high (Broxmeyer et al, 
1992; Hows et al, 1992; Lansdorp et al, 1993; Vormoor et al, 1994; 
Larochelle t al, 1996). These data suggest hat a single UCB collection 
should suffice for repopulation ofthe haemopoietic system of an adult. Such 
transplants have shown in adults long post-engraftment intervals to platelet 
and neutrophil recovery. Although this could have resulted from the trans- 
fusion of too few primitive HSCs, an alternative explanation could be that 
merely the number of transient repopulating HSC and progenitors i  limited 
in UCB grafts. These observations therefore present a rationale for the 
growing number of studies wherein ex vivo 'expansion' of true HSCs and 
transient repopulating progenitor cells are investigated. Though impressive 
increases in CD34 ~ cells and progenitor cells have been reported, there, are 
limited reports on net increases in the LTC-IC or CAFC week-6-8 content 
of cultures initiated with human BMC (Koller et al, 1993; Zandstra et al, 
1994; Petzer et al, 1996; Breems et al, 1997). At the moment here is 
insufficient evidence that a net increase in long-term in vivo repopulating 
HSCs can be achieved by short-term bulk culture of a graft. In addition, we 
do not know how ex vivo propagation will affect he behaviour of HSCs in 
the recipient, including their post-transplantation homing to haemopoietic 
organs or ageing. Indeed, recent studies how that short in vitro incubations 
of both human and murine HSCs may result in significantly decreased seed- 
ing fractions and engraftment levels in conditioned (NOD/SCID) recipients 
(Van der Loo and Ploemacher, 1995; Larochelle t al, 1996). 
Future directions may include the development of: 
(a) proper HSC assays or phenotypical enumeration of HSC; 
(b) large-scale strategies for separation of tumour cells from healthy HSCs 
in autologous grafts; 
(c) methods to improve the homing of infused HSCs to the bone marrow, 
especially following in vitro propagation of HSC; 
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(d) alternative ways of transducing enes to HSC with high efficiency 
while preserving the quality of the graft; 
(e) molecular methods to regulate the expression of the transduced genes; 
(f) protocols that improve fficiency of HSC mobilization to the systemic 
circulation. 
SUMMARY 
The process of blood formation is sustained throughout an individual's life 
by a small population of HSCs. The HSC compartment represents a 
hierarchy of HSC subsets with decreasing proliferative ability. This hetero- 
geneity is reflected in the varying time periods that HSCs may contribute to 
the initiation and maintenance of donor-type haemopoietic multilineage 
chimerism in vivo. The phenotype of HSC is incompletely defined render- 
ing morphological or flow-cytometric quantitation using cell surface and 
intracellular markers not fully reliable. Functional HSC assays, both in 
vitro (CAFC, LTC-IC) and in vivo (repopulation ofNOD/SCID mice) may 
be superior to phenotypic analysis, but such assays have not been truly 
validated in a human transplant setting. The quiescence and proliferation of 
HSCs is highly regulated by the stroma in haemopoietic organs. Many of 
the cytokines that have been cloned in recent years are actually elaborated 
and presented by the haemopoietic organ stroma cells and are supposed to 
serve as local regulators in order to gain specificity and avoid pleiotropic 
and thus undesired side-effects. Most probably, additional stroma-derived 
factors will be characterized, as suggested by the observation that HSCs 
produce more progeny in stroma-contact than in its absence or in stroma- 
conditioned medium, irrespective of the exogenous cytokines included. 
Stem cells are considered to possess the ability to self-renew and are 
therefore attractive vehicles for gene therapy. This assumed characteristic 
has fuelled attempts to amplify their numbers ex vivo, and is expected to 
enable more rapid haemopoietic recovery of conditioned recipients as well 
as enlarge HSC grafts of insufficient size before actual transplantation. 
REFERENCES 
*Abkovitz JL, Linenberger ML, Newton MA et al (1990) Evidence for the maintenance of 
hematopoiesis in a large animal by the sequential ctivation of stem-cell clones. Proceedings of 
the National Academy of Sciences of the USA 87: 9062-9066. 
Baum CM, Weissman CL, Tsukamoto AS et al (1992) Isolation of a candidate human hematopoietic 
stem-cell population. Proceedings of the National Academy of Sciences of the USA 89: 
2804-2808. 
Berardi AC, Wang A, Levine JD (1995) Functional isolation and characterization f human 
hematopoietic stem cells. Science 267: 104-108. 
Boggs DR, Bogs SS, Saxe DF et al (1982) Hematopoietic stem cells with high proliferative potential: 
assay of their concentration i  marrow by the frequency and duration of cure of W/Wv mice. 
Journal of Clinical Investigations 70: 242-253. 
B ordignon C, Notarangelo L, Nobili Net al (1995) Gene therapy in peripheral blood lymphocytes and 
bone marrow for ADA-immunodeficient patients. Science 270: 470-475. 
440 R .E .  PLOEMACHER 
Bradley TR & Metcalf D (1966) The growth of mouse bone marrow cells in vitro. Australian Journal 
of Experimental Biology & Medical Science 44: 287-299. 
*Breems DA, Blokland EAW, Neben S & Ploemacher RE (1994) Frequency analysis of human 
primitive haematopoietic stem c ll subsets using a cobblestone area forming cell assay. Leukemia 
8: 1095-t104. 
Breems DA, B lokland EAW & Ploemacher RE (1997) Stroma-conditioned media improve xpansion 
of human primitive hematopoietic stem cells and progenitors. Leukemia 11: 142-150. 
*Breems DA, van Hennik PB, Kusadasi N et al (1996) Individual stem cell quality in leukapheresis 
product is related to the number of mobilized stem cells as determined using long-term culture 
and cobblestone area forming cell assays. Blood 87: 5370-5378. 
Broxmeyer HE, Hangoc G, Cooper Set  al (1992) Growth characteristics and expansion of human 
umbilical cord blood and estimation of its potential for transplantation in adults. Proceedings of 
the National Academy of Sciences of the USA 89: 41094113. 
Broxmeyer HE, Lu L, Gaddy Jet al (1995) In Levitt D & Mertelsmann R (eds) Hematopoietic Stem 
Cells: Biology and Therapeutic Applications, pp 297-317. New York: Marcel Dekker. 
Capel B, Hawley RG & Mintz B (1990) Long- and short-lived murine hematopoietic st m cell clones 
individually identified with retroviral integration markers. Blood 75: 2267-2270. 
Capel B, Hawley R, Covarrubias Let  al (1989) Clonal contributions of small numbers of retrovirally 
marked hematopoietic stem cells engrafted in unirradiated neonatal W/Wv mice. Proceedings of 
the National Academy of Sciences of the USA 86: 4564--4568. 
Chaudhari PM & Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux 
pump, in human hematopoietic stem cells. Cell 66: 748-755. 
Cornelissen J J, Wognum AW, Ploemacber RE et al (1997) Efficient long-term aintenance of chronic 
myeloid leukemic obblestone area forming cells on a murine stromal cell line. Leukemia 11: 
126-133. 
Craig W, Kay R, Cutler R & Lansdorp PM (1993) Expression of Thy-1 on human hematopoietic 
progenitor cells. Journal of Experimental Medicine 177: 1331-1342. 
Dexter TM, Allen TD & Lajhta LG (1977) Condition controlling the proliferation of haemopoietic 
stem cells in vitro. Journal of Cellular Physiology 91: 335-342. 
Dick J (1996) Normal and leukemic human stem cells assayed in SCID mice. Seminars in 
Immunology 8: 197-206. 
Down JD & Ploemacher RE (1993) Transient and permanent engraftment potential of murine hemo- 
poietic stem cell subsets: differential effects of host conditioning with gamma radiation and 
cytotoxic drags. Experimental Hematology 21: 913-921. 
Down JD, Boudewijn A, Dillingh JH et al (1994) Relationships between ablation of distinct 
haematopoietic subsets and the development of donor bone marrow engraftment following 
recipient pretreatment with different alkylating drugs. British Journal of Cancer 70: 611- 
616. 
Down JD, Boudewijn A, Van Os R et al (1995) Variations in radiation dose-survival mong different 
bone marrow hemopoietic ell subsets following fractionated irradiation. Blood 86: 122- 
127. 
Dunbar CE, Cuttler-Fox M, O'Shaughnessy JA et al (1995) Retrovirally marked CD34-enriched 
peripheral blood and bone marrow cells contribute to long-term engraftment after autologous 
transplantation. Blood 85: 3048-3057. 
Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on 
platelet recovery after high-dose chemotherapy. Lancet 339: 640-644. 
Fraser CC, Eaves C J, Szilvassy SJ & Humphries RK (1990) Expansion in vitro of retrovirally marked 
totipotent hematopoietic stem cells. Blood 76: 1071-1076. 
Fruehauf S, Breems DA, Knafin-Shanzer Set  al (1996) Frequency analysis of multidrug Resistance- 
1 Gene transfer into human primitive hemopoietic progenitor cells using the cobblestone area 
forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine- 
123. Human Gene Therapy 7: 1219-1231. 
Gartner S & Kaplan HS (1980) Long-term culture of human bone marrow cells. Proceedings of the 
National Academy of Sciences of the USA 77: 4756-4759. 
Gunji Y, Nakamura M, Hagiwara T et al (1992) Expression and function of adhesion molecules on 
human hematopoietic stem cells: CD34+LFA-t cells are more primitive than CD34+LFA1 + cells. 
Blood 80: 429-436. 
Hampson J, Ponting ILO, Cook Net al (1989) The effects of TGF[3 on haemopoietic cells. Givwth 
Factors 1: 193-202. 
STEM CELLS 441 
Hao Q-L, Thiemann FT, Petersen D et al (1996) Extended long-term culture reveals ahighly quiescent 
and primitive human hematopoietic progenitor population. Blood 88:3306-3313. 
Harrison DE (1992) Evaluating functional abilities of primitive hematopoietic stem cell populations. 
In Muller-Sieburg C, Torok-Storb B, Visser J &. Storb R (eds) Current Topics in Microbiology 
and Immunology, Vol. 177, pp 13-30. Berlin: Springer Verlag. 
Harrison DE, Astle CM & Lemer C (1988) Number and continuous proliferation pattern of trans- 
planted primitive immunohemopoietic stem cells. Proceedings of the National Academy of 
Sciences of the USA 85: 822-826. 
Hatzfeld J, Li M-L, Brown E et al (1991) Release of early human hematopoietic progenitors from 
quiescence by antisense transforming rowth factor [31 or Rb oligonucleotides. Journal of 
Experimental Medicine 174: 925-929. 
Hirata T, Morii E, Mofimoto M et al (1993) Stem cell factor induces outgrowth of c-kit-positive 
neurites and supports the survival of c-kit-positive neurons in dorsal root ganglia of mouse 
embryos. Development 119: 49-56. 
Hodgson GS & Bradley TR (1984) In vivo kinetic status of hematopoietic stem and progenitor cells 
as inferred from labeling with bromodeoxyuridine. Experimental Hematology 12: 683-687. 
Hoogerbrugge PM, van Beusechem VW, Fischer A et al (1996) Bone marrow gene transfer in three 
patients with adenosine d aminase deficiency. Gene Therapy 3: 179-183. 
Hows JM, Bradley BA, Marsh JCW et al (1992) Growth of human umbilical cord blood in long term 
haematopoietic cultures, Lancet 340: 73-76. 
Jordan CT & Lemischka IR (1990) Clonal and systemic analysis of long-term hematopoiesis in the 
mouse. Genes and Development 4: 220-232. 
Kodama H, Nose M, Niida Set  al (1994) Involvement of the c-kit receptor in the adhesion of 
hematopoietic stem cells to stromal cells. E~perimental Hematology 22: 979-84. 
Kohn DB, Weinber KI, Nolta JA et al (1995) Engraftment ofgene-modified umbilical cord blood cells 
in neonates with adenosine deaminase deficiency. Nature Medicine 1: 1017-1023. 
Koller MR, Emerson SG & Palsson BO (I993) Large-scale expansion of human stem and progenitor 
cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82: 378- 
384. 
Korn AP, Henkelman RM, Ottensmayer FP & Till JE (1973) Investigations of a stochastic model of 
hematopoiesis. Experimental Hematology 1: 362-375. 
Lansdorp PM, Dragowska W & Mayani H (1993) Ontogeny-related changes in proliferative potential 
of human hematopoietic cells. Journal of Experimental Medicine 178: 787-791. 
Lapidot T, Pflumio F, Doedens Met  al (1992) Cytokine stimulation of multilineage hematopoiesis 
from immature human cells engrafted in scid mice. Science 255:1 t37-1141. 
*Larochelle A, Vormoor J, Hanenberg H et al (1996) Nature Medicine 2: 1329-1337. 
Leemhuis T, Yoder MC, Grigsby Set  al (1996) Isolation of primitive human bone marrow hemato- 
poietic progenitor cells using Hoechst 33342 and Rhodamine 123. Experimental Hematology 24: 
1215-1224. 
*Lemischka IR (1992) What we have learned from retroviral marking of hematopoietic stem cells. In 
Muller-Sieburg C, Torok-Storb B, Visser J & Storb R (eds) Current Topics in Microbiology and 
Immunology, Vol. 177, pp 59-71. Berlin: Springer Verlag. 
Lemischka IR, Raulet DH & Mulligan RC (1986) Developmental potential and dynamic behavior of 
hematopoietic stem ceils. Ceil 45: 917-927. 
Van der Loo JCM & Ploemacher RE (1995) Marrow and spleen seeding efficiencies of all murine 
hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth 
factors. Blood 85: 2598-2606. 
Van der Loo JCM, Van den Bos C, Baert MRM et al (1994) Stable multilineage hematopoiesis 
chimerism in alpha-thalassemic ice induced by a bone marrow subpopulation that excludes the 
majority of day-12 spleen colony-forming units. Blood 83: 1769-1777. 
Mauch R Greenberger JS, Botnick Let  al (1980) Evidence for structured variation in self-renewal 
capacity within long-term bone marrow cultures. Proceedings of the National Academy of 
Sciences of the USA 77: 2927-2930. 
Meijne EIM, Ploemacher RE, Vos O & Huiskamp R (1992) The effects of graded doses of 1 MeV 
fission neutrons or X-rays on the murine hematopoietic stroma. Radiation Research 131: 
302-308. 
Meijne EIM, Van der Winden-Van Groenenwegen AJM, Ploemacher RE et al (1991) The effects of 
X-irradiation on hematopoietic stem cellcompartments in the mouse. Experimental Hematology 
19: 617-623. 
442 R. E. PLOEMACHER 
Moore MAS & Hoskins I (1994) Ex vivo expansion of cord blood-derived stem cells and progenitors. 
Blood Cells 20:468-481. 
Muench MO & Moore MA (1992) Accelerated recovery of peripheral blood cell counts in mice trans- 
planted with in vitro cytokine-expanded hematopoietic progenitors. Experimental Hematology 
20: 611-618. 
Murray L, Chen B, Galy A et al (1995) Enrichment of human hematopoietic stem cell activity in the 
CD34÷Thy+Lin - subpopulation from mobilized peripheral blood. Blood 85: 368-378. 
Nakahata T, Gross AF & Ogawa M (1982) A stochastic model of the primitive hemopoietic s ern cells 
in culture. Journal of Cellular Physiology 113: 455-458. 
Nishikawa S, Kusakabe M, Yoshinaga K et al (1991) In utero manipulation of coat color formation 
by a monoclonal nti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte 
development. EMBO Journal 10: 2111-2118. 
Nolta JA, Hanley MB & Kohan DB (1994) Sustained human hematopoiesis in immunodeficient mice 
by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene trans- 
duction of long-lived progenitors. Blood 82:3041-3051. 
Ogawa M, Nishikawa, Yoshinaga Hayashi S et al (1993) Expression and function of c-kit in fetal 
hemopoietic progenitor cells: transition from the early c-kit-independent to the late c-kit- 
dependent wave of hemopoiesis in the murine embryo. Development 117:1089-1098. 
Ottmann OG & Pelus LM (1988) Differential proliferative effects of transforming growth factor-~ on 
human hematopoietic progenitor cells. Journal ofhnmunology 140: 2661-2667. 
Packer AI, Hsu YC, Besmer P & Bachvarova RF (1994) The ligand of the c-kit receptor promotes 
oocyte growth. Developmental Biology 161: 194-205. 
Pawliuk R, Eaves C & Humphries RK (1996) Evidence of both ontogeny and transplant dose- 
regulated expansion of hematopoietic stem cells in vivo. Blood 88: 2852-2858. 
Pettengell R, Luft T, Henschler R et al (1994) Direct comparison by limiting dilution analysis of long- 
term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem ceils. 
Blood 84: 3653-3659. 
Petzer AL, Zandstra PW, Piret JM & Eaves CJ (1996) Differential cytokine effects on primitive 
(CD34+CD38 -) human hematopoietic ceils: novel responses to Flt3-1igand and th_rombopoietin. 
Journal of Experimental Medicine 183: 2551-2558. 
*Petzer AL, Hogge DE, Landsdorp PM et al (1996) Self-renewal of primitive human hematopoietic 
cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. 
Proceedings of the National Academy of Sciences of the USA 93: 1470-1474. 
Ploemacher RE (1994) Cobblestone area forming cell (CAFC) assay. In Freshney RI, PragneU IB & 
Freshney MG (eds) CRC Culture of Specialised Cells, Vol. 2, pp 1-21. New York: Wiley-Liss 
Inc. 
Ploemacher RE & Brons NHC (1988a) Cells with marrow and spleen repopulating ability and 
forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing 
rhodamine 123 retention. Journal of Cellular Physiology 136:531-536. 
Ptoemacher RE & Brons NHC (1988b) In vivo proliferative and differential properties of murine bone 
marrow cells separated on the basis of rhodamine-123 retention. Experimental Hematology 16: 
903-907. 
Ploemacher RE & Brons NHC (1989) Separation of CFU-S from primitive ceils responsible for 
reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: 
evidence fbr a pre-CFU-S cell. Experimental Hematology 17: 263-266. 
Ploemacher RE, Van Soest PL & Boudewijn A (t993a) Autocrine transforming growth factor-131 
blocks colony formation a d progenitor cell generation by hemopoietic stem ceils stimulated 
with steel factor. Stem Cells 11: 336-347. 
*Ploemacher RE, Van der Loo JCM, Van Beurden CAJ & Baert MRM (1993b). Wheat germ agglutinin 
affinity of routine hemopoietic stem cell subpopulations is an inverse function of their long-term 
repopulating ability in vitro and in vivo. Leukemia 7: 120-130. 
*Ploemacher RE, Van der Sluijs JP, Voerman JSA & Brons NHC (1989) An in vitro limiting-dilution 
assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74: 2755- 
2763. 
Ploemacher RE, Van Os R, Van Beurden CAJ & Down JD (1992) Murine hemopoietic stem c lls with 
long term engraftment and marrow repopulating ability are more resistant to gamma radiation 
than are spleen colony forming cells. International Journal of Radiation Biology 61: 489- 
499. 
Ploemacher RE, Van der Sluijs JP, Van Beurden CAJ et al (1991) Use of limiting dilution type long- 
STEM CELLS 443 
term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming 
hematopoietic stem cells in the mouse. Blood 78: 2527-2533. 
Ploemacher RE, Mayen AEM, de Koning AE et al (in press) Gap junction intercellular communica- 
tion is likely to be involved in regulation of stroma-dependent proliferation of hemopoietic stem 
cells. In Greenberger P & Keating A (eds) Keystone Conference on Stroma and Megakaryo- 
poiesis February 1996. Cambridge: Cambridge University Press. 
Pluznik DH & Sachs L (1965) The cloning of normal 'mast' cells in tissue culture. Journal of Cellular 
Physiology 66: 319-324. 
Rosendaal M, Hodgson GS & Bradley TR (1979) Organization of hemopoietic stem cells: the 
generation-age hypothesis. Cell Tissue Kinetics 12:17-29. 
Rosenda~ M, Green CR, Rahman A & Morgan D (1994) UP-regulation of the connexin43* gap 
junction etwork in haemopoietic tissue before the growth of stem cells. Journal of Cell Science 
107: 29-37. 
Rosendaal M, Mayen AEM, De Koning A et al (in press) Does transmembrane communi- 
cation through gap junctions enable stem cells to overcome stromal inhibition? Leukemia (in 
press). 
Ruscetti FW, Dubois C, Falk LA et al (1991 ) In vivo and in vitro effects of TGF-beta 1 on normal and 
neoplastic haemopoiesis. Oba-Foundation-Symposium 157:212-227. 
Van der Sluijs JP, Van den Bos C, Baert MRM et al (1993) Loss of long-term repopulating ability in 
long-term bone marrow culture. Leukemia 7: 725-732. 
Snodgrass R & Keller G (1987) Clonal fluctuation within the hematopoietic system in mice reconsti- 
tuted with retrovirus-infected c lls. EMBO Journal 6: 3955-3960. 
*Spangrude G, Brooks DM & Tumas DB (1995) Long-term repopulation of irradiated mice with 
limiting numbers of purified hematopoietic stem cells: in vivo expansion f stem cell phenotype 
but not function. Blood 85: 1006-1016. 
Srour EF, Bregni M, Traycoff CM et al (1996) Long-term hematopoietic culture-initiating cells are 
more abundant inmobilized peripheral blood grafts than in bone marrow but have a more limited 
ex vivo expansion potential. Blood Cells, Molecules & Diseases 22: 68-81, 
Suda T, Suda J & Ogawa M (1983) Proliferative kinetics and differentiation of murine blast cell 
colonies in culture: evidence for variable G o periods and constant doubling rates of early pluri- 
potent hemopoietic progenitors. Journal of Cellular Physiology 117:308-318. 
*Sutherland HJ, Lansdorp PM, Henkelman DH et al (1990) Functional characterization f individual 
human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal 
layers. Proceedings of the National Academy of Sciences of the USA 87: 3584-3588. 
Suthefland HJ, Eaves CJ, Lansdorp PM et al (1991) Differential regulation of primitive human 
hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal 
cells. Blood 78: 666-672. 
Szitvassy SJ, Lansdorp PM, Humphries RK et al (1989) Isolation in a single step of a highly enriched 
murine hematopoietic stem cell population with competitive long-term repopulating ability. 
Blood 74: 930-939. 
Terpstra W, Ploemacher RE, Prins A et al (1996a) Fluorouracil spares AML cells with tong term 
abilities in immunodeficient mice and in stromal culture. Blood 88: 1944-1950. 
Terpstra W, Prins A, Ploemacher RE et al (1996b) Long term leukemia initiating capacity of a CD34 
negative subpopulation f acute myeloid leukemia. Blood 87:2187-2194. 
Till JE & McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse 
bone marrow cells. Radiation Research 14: 213-222. 
Tsuji K, Zsebo KM & Ogawa M (1991) Enhancement of murine blast cell colony formation in culture 
by recombinant s em cell factor (rrSCF), ligand for c-kit. Blood 78: 1223-1229. 
Vaziri H, Dragowska W, Allsopp RC et al (1994) Evidence for a mitotic clock inhuman hematopoietic 
stem cells: loss of telomeric DNA with age. Proceedings of the National Academy of Sciences of 
the USA 91: 9857-9860. 
Vormoor J, Lapidot T, Pflumio F et al (1994) Immature human cord blood progenitors engraft and 
proliferate to high levels in immune-deficient SCID mice. Blood 83: 2489-2497, 
Wang JCY, Doedens M & Dick JE (1997) Primitive haemopoietic ceils are enriched in cord blood 
compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative 
in vivo SCID-repopulating assay. Blood 89: 3919-3924. 
Winton EF & Colenda KW (1987) Use of long-term human marrow cultures to demonstrate 
progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide. Exp ri- 
mental Hematology 15: 710-714. 
444 R. E. PLOEMACHER 
Yoshinaga K, Nishikawa S, Ogawa Met al (1991) Role of c-kit in mouse spermatogenesis: identifi- 
cation of spermatogonia as a specific site of c-kit expression and function. Development 113: 
689-699. 
Zandstra PW, Eaves CJ & Piret JM (1994) Expansion of hematopoietic progenitor cell populations in
stirred suspension bioreactors of normal human bone marrow cells. BioTechnology 12:909-914. 
